Top Aces Inc. (“Top Aces” or the “Company”), a global leader in advanced operational training for military forces, proudly announces the award of a 10-year contract worth up to €420 Million by the German Armed Forces (Bundeswehr). Building on a decade of trusted service, this new agreement - officially titled “Contracted Fast Adversary Air” (Vertrag Schnelle Flugzieldarstellung) - will deliver mission-critical operational training across Germany’s Air Force, Army, and Navy.

“This contract marks a significant milestone in our long-standing partnership with the Bundeswehr,” said Thomas Beringer, Vice-President Europe, Top Aces. “We are honoured to continue supporting Germany’s operational readiness - an imperative in today’s complex global landscape - with world-class training solutions tailored to the evolving needs of its armed forces.”

Under this landmark agreement, Top Aces will provide a comprehensive suite of training capabilities designed to strengthen operational readiness across all branches of the Bundeswehr. Training will be conducted using Top Aces’ diverse fleet, featuring A-4N Skyhawk aircraft equipped with Active Electronically Scanned Array (AESA) radar and highly upgraded Alpha Jets. Leveraging an open architecture design, Top Aces’ proprietary ‘Advanced Aggressor Mission System’ (AAMS) enables the A-4Ns to integrate advanced sensors, effectively replicating the threats posed by modern adversary fighter aircraft.

Didier Toussaint, Group President and Co-Founder of Top Aces, added: “We are deeply grateful for the continued trust placed in us by the German Armed Forces. This contract reflects the strength of our partnership and the consistent value our team strives to deliver. As we grow internationally, our focus remains on supporting our customers with reliable, innovative training solutions that enhance mission readiness and operational effectiveness.”

This award further solidifies Top Aces’ leadership in the global defense and aerospace sectors, highlighting its commitment to delivering cost-effective, cutting-edge solutions that enhance preparedness across NATO and allied nations. As the world’s safest commercial provider of advanced operational training, Top Aces continues to set the industry standard - offering armed forces the most sophisticated solutions available.


Caution Regarding Forward-Looking and Other Statements
This news release contains certain statements that may constitute “forward-looking information” and “forward-looking statements” (collectively, “forward-looking statements”) within the meaning of applicable Canadian and United States securities laws, in particular regarding the expected duration of and revenue to be derived from the contract with the German Armed Forces. Forward-looking statements are necessarily based upon a number of estimates and assumptions that, while considered reasonable by the Company, are inherently subject to significant uncertainties and contingencies. There can be no assurance that forward-looking statements will prove to be accurate, as actual results and future events could differ materially from those anticipated in such statements. Accordingly, readers should not place undue reliance on forward-looking statements.

Statements regarding Top Aces’ market position are based on a variety of information sources, including third-party publications and management’s beliefs. As there can be no assurance as to the accuracy or completeness of such information, readers should not place undue reliance on such statements.

All statements in this news release speak only as of the date hereof and, except as required by law, the Company does not undertake any obligation to update or revise any such statements.


About Top Aces
With over 150,000 accident-free flight hours, Top Aces Inc. and its subsidiaries, including Top Aces Corp. and Blue Air Training Corp., provide advanced operational training to the world’s leading armed forces. In an industry where Experience Matters, Top Aces boasts the largest and most advanced fleet of commercially operated fighter aircraft in active service and is the world’s only commercial owner/operator of the F-16. Our mission-critical training enhances the operational readiness of combat forces by delivering real-world experience while creating significant cost efficiencies and extending the lifespan of military aircraft fleets. For more information, please visit www.topaces.com.


Follow Top Aces on Social Media:
X: https://x.com/topaces/
LinkedIn: https://www.linkedin.com/company/top-aces/
Instagram: https://www.instagram.com/topaces/
Facebook: https://www.facebook.com/topaces/


Media Contact:
Erin Black
Marketing Communications Manager, Top Aces
+1 (514) 694-7224
media@topaces.com

Photo: Richie Becke

held in Spain from March 26 to March 28. Following its successful debut at last year's conference, Carilex has established connections with more medical institutions and expanded its market presence. This year, the company will further enhance the European subsidiary's localized service to provide more professional and efficient support.

announced that its Negative Pressure Wound Therapy (NPWT) product series has successfully obtained certification under the EU Medical Device Regulation (MDR). The certification was issued by DNV, an EU-designated Notified Body, confirming compliance with MDR requirements for Class IIb medical devices. Carilex is currently the only Taiwan-based brand to have achieved MDR certification for NPWT products.

On August 14th, 2021, Ken Foote of Transupport attended an OV-1 Mohawk dedication in the memory of 1LT Robert Weiss and SP4 William Foster Jr at the Military Aviation Preservation Society (MAPS) Air Museum in North Canton, Ohio. Transupport was honored to donate this OV-1 Mohawk to the MAPS Air Museum to be refurbished and dedicated in the memory of these Vietnam Veterans. To learn more about the aircrafts history and to see the transformation it underwent please click the above link for more information!

Are you ready to transform your pharmacy operations?

Connect with our experts to explore how ARxIUM’s innovative medication management and automation solutions can address your unique challenges.

Whether you’re looking to improve inventory visibility, streamline compliance, or drive operational efficiency, our team is ready to provide actionable insights and a customized roadmap for success.

Take the first step toward transforming your pharmacy enterprise.

Today, Baylor University Medical Center at Dallas released details on the first four living-donor uterine transplants performed in the United States as part of a clinical trial under Institutional Review Board approval. These first four surgeries were performed in September.

This announcement comes after two years of preparation and a careful review of all 16 previous uterine transplants performed across the world, led by the passion and dedication of the Baylor University Medical Center surgical team.

“The implication going from an organ that saves lives to an organ that produces lives is simply fascinating to me, and I became infected with this idea,” said Giuliano Testa, MD, principal investigator and surgical chief of abdominal transplantation at Baylor University Medical Center at Dallas.

World's largest uterus transplant program now offers more women the opportunity to achieve a pregnancy
Becoming a mother is a monumental moment. At Baylor Scott & White Health, we want all mothers to cherish the unique moments of their pregnancy and childbirth.

Yet, despite this investment level, life sciences and biotech sector also has some of the lowest adoption rates and one of the highest proportions of organizations reporting that AI projects fell short of expectations. The number one barrier? Data quality. For safety-critical areas like drug discovery, clinical trials, and regulatory research, poor data integration and governance continue to limit AI’s full potential.

At Tech World @ CES 2026 at Sphere in Las Vegas, Lenovo unveiled the boldest innovations yet for the future of Hybrid AI, introducing a new personal AI super agent, AI PCs and smartphones, proofs of concept including agentic-native wearables, next-generation enterprise AI infrastructure, and breakthrough industry collaborations in entertainment and sports.

Cedars-Sinai is boosting its innovation efforts by launching a Digital Innovation Platform in partnership with venture builder Redesign Health to create and grow digital health startups focused on solving major healthcare challenges like personalized medicine, specialty care access, workflow optimization, clinical decision support, and improved care coordination. The platform differs from the existing Accelerator program by partnering entrepreneurs with Cedars-Sinai staff, investors, and startup builders to develop solutions from concept to launch, often based on ideas from clinicians and internal teams. The initiative supports new companies with early funding, expert guidance, and opportunities to pilot solutions in real hospital settings, giving Cedars-Sinai the role of first funder, customer, and pilot site. A key feature is access to large datasets that mimic real health information, helping startups design smarter tools and refine them with user feedback—strengthening the pathway from innovation to real-world impact.

Cedars-Sinai is embracing synthetic data to strengthen its machine learning and artificial intelligence capabilities for research and clinical initiatives. Synthetic data uses AI to generate datasets that reflect real patient characteristics and treatment patterns without exposing private information, enabling faster, privacy-preserving insights that support research and clinical decision-making more efficiently than traditional data retrieval methods.To implement this strategy, Cedars-Sinai partners with Syntho, an AI technology provider from Amsterdam that participated in its Accelerator program, and integrates synthetic data efforts with its new Digital Innovation Platform. Leaders in computational biomedicine at the health system are exploring how synthetic data lowers barriers to research, facilitates collaboration, and accelerates hypothesis testing, while also recognizing limitations in certain data types and the need for careful user communication.